Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Pancreatic Ductal × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 30 Colorectal Neoplasms 25 Neoplasms 20 Ovarian Neoplasms 19 Lung Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Head and Neck Neoplasms 14 Pancreatic Neoplasms 13 Neoplasm Metastasis 13 Leukemia, Myeloid, Acute 12 Lymphoma, Non-Hodgkin 11 Glioblastoma 11 Rectal Neoplasms 10 Fallopian Tube Neoplasms 10 Esophageal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lymphoma 9 Recurrence 8 Melanoma 8 Lymphoma, Follicular 8 Leukemia 8 Central Nervous System Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Squamous Cell 7 Carcinoma, Ovarian Epithelial 7 Lymphoma, Large B-Cell, Diffuse 6 Liver Neoplasms 6

Interventions

Gemcitabine 8 130-nm albumin-bound paclitaxel 5 Albumin-Bound Paclitaxel 4 napabucasin 2 Oxaliplatin 2 MK-4721 2 Leucovorin 2 Fluorouracil 2 Carboplatin 2 tremelimumab 1 irinotecan sucrosofate 1 ensituximab 1 durvalumab 1 contrast agent BR1 1 cc-486 1 Taxes 1 Practice Guidelines as Topic 1 Pancreaticoduodenectomy 1 Paclitaxel 1 PEGPH20 1 Lead 1 Irinotecan 1 Enoxaparin 1 EC regimen 1 Drug Therapy 1 Dexamethasone 1 Cisplatin 1 CP protocol 1 Azacitidine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04146441 2023-01-19

PDAC

St. Olavs Hospital

Phase 2 Completed

Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡